PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-4.71%
Negative net income growth while MCHP stands at 88.34%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-6.51%
Negative yoy D&A while MCHP is 1.81%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-67.39%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
124.78%
Well above MCHP's 32.74% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
134.62%
Inventory growth well above MCHP's 91.28%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
121.14%
Growth well above MCHP's 3.79%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-617.65%
Negative yoy while MCHP is 38.96%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
101.67%
Some CFO growth while MCHP is negative at -4.78%. John Neff would note a short-term liquidity lead over the competitor.
22.46%
Some CapEx rise while MCHP is negative at -89.66%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
4.40%
Some yoy expansion while MCHP is negative at -64.20%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-41.55%
We reduce yoy sales while MCHP is 185.88%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-97.00%
We reduce yoy invests while MCHP stands at 225.19%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-42.70%
Negative yoy issuance while MCHP is 19.96%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
33.33%
Buyback growth of 33.33% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.